State of Michigan Retirement System grew its holdings in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 0.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 54,309 shares of the company’s stock after acquiring an additional 100 shares during the quarter. State of Michigan Retirement System’s holdings in HCA Healthcare were worth $18,114,000, according to the most recent SEC filing.
Other major investors have also recently made changes to their positions in the company. Centerpoint Advisors LLC acquired a new stake in HCA Healthcare during the fourth quarter valued at approximately $27,000. Atlantic Edge Private Wealth Management LLC acquired a new stake in HCA Healthcare during the fourth quarter valued at approximately $27,000. Bruce G. Allen Investments LLC acquired a new stake in HCA Healthcare during the fourth quarter valued at approximately $28,000. Rise Advisors LLC acquired a new stake in HCA Healthcare during the first quarter valued at approximately $36,000. Finally, Northwest Investment Counselors LLC acquired a new stake in HCA Healthcare during the first quarter valued at approximately $36,000. 62.73% of the shares are currently owned by hedge funds and other institutional investors.
Insider activity
In other news, SVP Kathryn A. Torres sold 973 shares of the company’s stock in a transaction that occurred on Thursday, May 2. The shares were sold at an average price of $312.00, for a total transaction of $303,576.00. Following the completion of the transaction, the senior vice president now directly owns 22,365 shares of the company’s stock, valued at approximately $6,977,880. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In other news, EVP Michael S. Cuffe sold 1,600 shares of the company’s stock in a transaction that occurred on Monday, May 6. The shares were sold at an average price of $309.00, for a total transaction of $494,400.00. Following the completion of the transaction, the executive vice president now directly owns 34,124 shares of the company’s stock, valued at $10,544,316. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Kathryn A. Torres sold 973 shares of the company’s stock in a transaction dated Thursday, May 2. The shares were sold at an average price of $312.00, for a total transaction of $303,576.00. Following the completion of the transaction, the senior vice president now owns 22,365 shares of the company’s stock, valued at approximately $6,977,880. The disclosure regarding this sale can be found here. Insiders have sold 12,397 shares of the company’s stock valued at $3,921,929 in the last ninety days. Company insiders own 1.70% of the company’s stock.
Changes in analyst ratings
HCA has been the subject of several research analyst reports. Robert W. Baird initiated coverage on HCA Healthcare in a report on Thursday, May 30th. They issued an “outperform” rating and a $396.00 price target on the stock. Royal Bank of Canada increased their price target on HCA Healthcare from $322.00 to $329.00 and gave the company an “outperform” rating in a report on Monday, April 29th. Oppenheimer increased their price target on HCA Healthcare from $330.00 to $345.00 and gave the company an “outperform” rating in a report on Monday, April 29th. Deutsche Bank Aktiengesellschaft increased their price target on shares of HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research report on Friday, June 28th. Finally, JPMorgan Chase & Co. raised their price target on shares of HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a report on Thursday, May 30. Four investment analysts have rated the stock with a “hold,” thirteen have rated it with a “buy,” and two have given it a “strong buy.” Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $326.53.
Read our latest research report on HCA Healthcare
HCA Healthcare trading up 1.5%
HCA Healthcare stock opened at $319.70 on Wednesday. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $344.20. The stock has a market cap of $83.73 billion, a P/E ratio of 15.94, a PEG ratio of 1.49 and a beta of 1.68. The stock has a 50-day average price of $326.06 and a 200-day average price of $317.80. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings results on Friday, April 26. The company reported earnings per share (EPS) of $5.36 for the quarter, beating the consensus estimate of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The company posted revenue of $17.34 billion during the quarter, compared to analyst expectations of $16.81 billion. During the same quarter last year, the company posted earnings per share of $4.93. The company’s revenue grew by 11.2% year-over-year. Equities analysts forecast that HCA Healthcare, Inc. will report earnings per share of $20.92 for the current fiscal year.
Dividend announcement from HCA Healthcare
The company also recently announced a quarterly dividend, which was paid on Friday, June 28th. Investors of record on Friday, June 14th were given a dividend of $0.66 per share. This represents an annualized dividend of $2.64 and a yield of 0.83%. The ex-dividend date was Friday, June 14th. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.16%.
HCA Healthcare Profile
(Free report)
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and allied health facilities in the United States. The company operates general hospitals and acute care hospitals that provide medical and surgical services, including inpatient care, critical care, cardiology, diagnostics and emergency services, as well as outpatient services such as ambulatory surgery, laboratory, radiology, respiratory therapy, cardiology and physical therapy.
Read more
Want to see which other hedge funds hold HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Get daily news and reviews for HCA Healthcare – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for HCA Healthcare and related companies with MarketBeat.com’s FREE daily email newsletter.
